Sprout BioVentures

Sprout Bioventures is a Massachusetts-based venture capital firm investing in early-stage biotechnology companies. The firm focuses on opportunities with startups which are researching key insights in human biology and turning them into viable therapeutics. It pursues companies researching compelling targets which have emerged from population-wide genetic association studies, where human loss-of-function mutations point to an inhibitor strategy, and gain-of-function mutations provide a gene dose-response. Founded in 2018, the firm has invested in fourteen companies in fields of biotechnology, drug discovery, and drug delivery.